SphingoTec

Just pitched at #FinanceDay2026 in Leipzig! 🎤Critical care biomarkers, stand-alone and as companion diagnostics. Thank you to GoingPublic Media, Plattform Life Sciences and moderator Viola Bronsema, and to the investors for great questions. Come say hi! 🤝

Can a blood test flag severe kidney injury early? 🩸A poster at #KidneyWeek2026 shows penKid helped identify hospitalized patients at highest risk of persistent severe AKI, especially in the ICU. 📍Exhibit Hall A, 22 Oct, 10:00 AM-12:00 PM, Denver. #AKI #Nephrology #CriticalCare

On 22 Oct, Deborah Bergmann & Nicole Witzmann will represent SphingoTec at #FinanceDay2026 in Leipzig. 🎤We pitch in “National Heroes” at 14:15: critical care biomarkers, stand-alone and as companion diagnostics. Investors, let’s connect! #Diagnostics #PersonalizedMedicine

💡 penKid adds value beyond serum creatinine in sepsis, enabling earlier risk stratification for renal deterioration and short-term mortality. New Next GeneSiS data at #LIVES2026 from University Hospital Essen researchers. #Sepsis #AKI #ESICM #SphingoTec#penKid

See you at #LIVES2026 in Lisbon, Oct 10-14! Deborah Bergmann, Martina Kalle Brune, and Marlene Gotschalk are open to discussions. Join Boditech Med and us on Mon, Oct 12 for the Expert Meeting on the AFIAS sphingotest® penKid®. Also featuring penKid poster. #ESICM #Sepsis #penKid

Kidney health is the focus in Leipzig this week! SphingoTec is at #DGFN2026 (Oct 8-11). Deborah Bergmann (CEO) and Martina Kalle Brune (Medical Affairs) are open to discussing kidney function biomarkers and future collaborations with the nephrology community. Let's connect! 👋

New Study Suggests Potential of penKid in Kidney Reserve Assessment PenKid has been evaluated for the first time as a marker of kidney functional reserve (KFR) Read the press release here: sphingotec.eu/new-study-sugg…

👋 Welcome to the team, Dr. Marlene Gottschalk! Her focus: meaningful scientific exchange with clinicians and researchers, supporting evidence generation, and bringing real‑world insights back into our medical strategy. #SphingoTec #MedicalAffairs #MSL #CriticalCare #Biomarkers

🔬 SphingoTec at DGAI 2026 – Kassel If you’re attending DGAI, feel free to reach out to arrange a meeting during the congress. #SphingoTec #DGAI2026 #CriticalCare #Intensivmedizin #Biomarkers #penKid #bioADM #MedicalAffairs

New publication on proenkephalin A 119–159 (penKid) in critically ill patients: In a prospective, real-world study of 1,436 critically ill ICU patients, penKid provided clinically relevant information across AKI severity and during KRT. sphingotec.eu/news

SphingoTec at major 2026 conferences: - DGAI, Sep 16–18, Kassel - DGFN, Oct 8–11, Leipzig - ESICM Lives, Oct 10–14, Lisbon – Symposium + penKid sepsis poster - ASN Kidney Week, Oct 22–25, Denver – penKid poster on AKI - Medica, Nov 16–19, Düsseldorf - DIVI, Dec 2–4, Hamburg

SphingoTec CEO Deborah Bergmann will attend ADLM 2026 (July 26–30). We’re looking to connect with partners to explore collaborations in critical care diagnostics. Interested in meeting? Get in touch. sphingotec.eu/sphingotec-ceo… #CriticalCare #Diagnostics

Meta-analysis: elevated penKid flags sepsis/septic shock patients at risk for worsening renal function & mortality — even with normal creatinine. For routine use: AFIAS sphingotest® penKid® → boditech.co.kr/en/product/re… 📄Study: link.springer.com/article/10… #penKid #Sepsis #AKI

Study: penKid outperforms creatinine in detecting delayed graft function on Day 1 post-transplant. 📄 Publication: pubmed.ncbi.nlm.nih.gov/4047… For research applications: ELISA sphingotest® penKid® → sphingotec.eu/product/ELISA-…

Prospective study: penKid levels differ significantly between cardiac surgery patients successfully vs. unsuccessfully liberated from CRRT. pubmed.ncbi.nlm.nih.gov/3945… Investigate this approach in your own research: ELISA sphingotest® penKid® → sphingotec.eu/product/ELISA-…

Consistency matters: The ELISA sphingotest® penKid® delivers proven correlation to SphingoTec’s reference chemiluminescence assay, ensuring analytical continuity across platforms. #SphingoTec #Quality #BiomarkerValidation #AnalyticalPerformance #penKid

Welcome back to SphingoTec, Maria Schulz. As R&D Associate, she supports biomarker assay development, data analysis, and lab operations. #RandD #Biomarkers #Diagnostics #LifeSciences

AFIAS sphingotest® penKid® on AFIAS 1, 3, 6, 10 analyzers. Time-Resolved Fluorescence. Validated kidney biomarker for rapid results. Reliable. Decentralized. #penKid #AFIAS #IVDR #Diagnostics

SphingoTec at Vicenza 2026—once again. Meet our Director Medical Affairs, Dr. Martina Kalle-Brune, and exchange on the latest developments in biomarker research and clinical application. #Vicenza2026 #CriticalCare #Biomarkers

We are pleased to welcome Dr. Martina Kalle-Brune as Director Medical Affairs at SphingoTec. She will lead Medical & Scientific Affairs and help expand the reach of our biomarkers from research into clinical routine. Welcome to the team, Martina. #MedicalAffairs #Biomarkers